Science Explorer Interactive view Map
Company · Rome · Italy

Novo Nordisk (Italy)

novonordisk.itROR OpenAlex
Research works
105
▼ 47% vs 2013–17
Citations
1.3k
12.0 per fractional work
Top-10% rate
13.7%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: Novo Nordisk (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.72× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.06× its world share, 0 worksImmunology and Micro…Neuroscience: 0.20× its world share, 0 worksNeuroscienceComputer Science: 0.46× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.28× its world share, 0 worksEarth and Planetary …Engineering: 0.07× its world share, 0 worksEngineeringEnvironmental Science: 0.44× its world share, 1 worksEnvironmental ScienceDentistry: 0.90× its world share, 0 worksDentistryHealth Professions: 1.83× its world share, 1 worksHealth ProfessionsMedicine: 3.16× its world share, 16 worksMedicineArts and Humanities: 0.30× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.67× its world share, 1 worksBusiness, Management…Decision Sciences: 2.03× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.36× its world share, 1 worksEconomics, Econometr…Psychology: 0.55× its world share, 0 worksPsychologySocial Sciences: 0.42× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.2×. Every wedge is a field page.

Who are the top researchers at Novo Nordisk (Italy)?

Ranked on the composite score, Adam J. Kerr lead among researchers whose main affiliation is Novo Nordisk (Italy).

  1. 1 Adam J. Kerr Italy · #824,226 worldwide 26 citations · 17 works
All ranked researchers at Novo Nordisk (Italy)

Which keywords describe research at Novo Nordisk (Italy)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Diabetes, Obesity, Heart Failure, Cardiovascular Outcomes and Glucose Control.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Glycemic Control5▲ 136×4 topics
  2. Insulin Therapy5▲ 152×3 topics
  3. Type 2 Diabetes4▲ 75×3 topics
  4. Diabetes4▲ 31×6 topics
  5. Obesity4▲ 20×9 topics
  6. Heart Failure4▲ 34×4 topics
  7. Cardiovascular Outcomes4▲ 251×1 topic
  8. Glucose Control4▲ 251×1 topic
  9. Cardiovascular Disease3▲ 11×7 topics
  10. Metabolic Syndrome3▲ 13×6 topics
  11. Weight Loss2▲ 54×4 topics
  12. Inflammation2▲ 3.9×16 topics
  13. Lifestyle Intervention2▲ 95×2 topics
  14. Insulin Resistance2▲ 16×4 topics
  15. Glucose Metabolism2▲ 59×2 topics
  16. Atherosclerosis1▲ 20×2 topics
  17. Cholesterol1▲ 40×2 topics
  18. Global Prevalence1▲ 60×1 topic
  19. Primary Care1▲ 14×3 topics
  20. Health Outcomes1▲ 17×4 topics
  21. Type 1 Diabetes1▲ 55×2 topics
  22. Anti-Obesity Drugs1▲ 234×1 topic
  23. Clinical Trials1▲ 6.4×2 topics
  24. Continuous Glucose Monitoring1▲ 92×1 topic
  25. Hypoglycemia1▲ 92×1 topic
  26. Pharmacotherapy1▲ 209×1 topic
  27. Cancer1▲ 3.0×7 topics
  28. Cancer Risk1▲ 19×2 topics
  29. Public Health1▲ 2.8×3 topics

Which research topics does Novo Nordisk (Italy) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Research and Pharmacology and Obesity Treatment.

Diabetes Treatment and M…4Diabetes Treatment and Management: 4 fractional worksDiabetes, Cardiovascular…1Diabetes, Cardiovascular Risks, and Lipoproteins: 1 fractional worksDiabetes Management and …1Diabetes Management and Research: 1 fractional worksPharmacology and Obesity Treatment: 1 fractional worksMetabolism, Diabetes, and Cancer: 1 fractional worksBariatric Surgery and Ou…1Bariatric Surgery and Outcomes: 1 fractional worksObesity and Health Practices: 1 fractional worksDiabetes Management and Education: 1 fractional worksGrowth Hormone and Insulin-like Growth Factors: 1 fractional worksDiet and metabolism studies: 0 fractional works
Endocrinology, Diabetes and MetabolismPharmacologyMolecular BiologySurgery2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 4 works
  2. 2 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
  3. 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
  4. 4 Pharmacology and Obesity Treatment Pharmacology 1 works
  5. 5 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
  6. 6 Bariatric Surgery and Outcomes Surgery 1 works
  7. 7 Obesity and Health Practices Pharmacy 1 works
  8. 8 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 1 works
  9. 9 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 1 works
  10. 10 Diet and metabolism studies Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.6%not open54.4%

World: 28% of research is openly available.

with international co-authors46.6%domestic only53.4%

World: 19% is written across borders.

How has Novo Nordisk (Italy)'s research output changed?

Output in 2018–2022 was 47% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rome

All research institutions in Rome

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.